RPRD Diagnostics logo — pharmacogenetics, pharmacogenomics, precision medicine, diag...

RPRD Diagnostics

pharmacogenetics, pharmacogenomics, precision medicine, diagnostic testing, genetics testing, gene-drug test

Founded 2016 9 employees Biotechnology, Health Care +1

General Information

Company Name RPRD Diagnostics
Founded Year 2016
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when RPRD Diagnostics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About RPRD Diagnostics

RPRD Diagnostics is a precision medicine company specializing in clinical pharmacogenomics (PGx) testing and analysis services for healthcare providers and pharmaceutical companies globally. The company is renowned as the PGx reference lab of choice for the leading pediatric cancer centers in the nation, as per the US News and World Report rankings for 2019-2020. Founded in 2016, RPRD Diagnostics' results from PGx tests are utilized by healthcare providers to enhance clinical decision-making, ultimately improving patient outcomes and reducing expenses. The company's focus includes comprehensive PGx and tailored panels, such as the CNT Panel for identifying leukemia patients at risk of toxicity from thiopurine drugs. These tests empower physicians to consider a patient's unique genetic profile when recommending drug treatment. RPRD Diagnostics operates in the Biotechnology, Health Care, and Pharmaceutical sectors, holding great potential for growth and impact in the precision medicine landscape. While specific details concerning the company's headquarters and recent investment are not available at this time, the impact of RPRD Diagnostics on patient care and the pharmaceutical industry is noteworthy.

Taxonomy: Precision Medicine, Pharmacogenomics, Diagnostic Testing, Genetics Testing, PGx Reference Lab, Clinical Decision-making Support, Pediatric Cancer Centers, Toxicity Risk Identification, DNA Sequencing, Pharmacogenetics, Leukemia Patient Care, Healthcare Providers, Pharmaceutical Companies

No funding data available for RPRD Diagnostics yet.

Get notified when RPRD Diagnostics raises funding

RPRD Diagnostics Alternatives & Competitors

RPRD Diagnostics vs

Providing genetic and molecular diagnostic solutions to advance healthcare.

5 employees
Health Care
RPRD Diagnostics vs
Selah Genomics Inc
Selah Genomics Inc United States

Selah Genomics is a personalized medicine diagnostic specialist supporting healthcare providers and...

Debt Financing
1 employees
Biotechnology, Health Care
RPRD Diagnostics vs
Genelex
Genelex United States

Genelex has been a leader in molecular diagnostics and genetic testing for more than 30 years.

22 employees
Biotechnology

FAQ About RPRD Diagnostics

pharmacogenetics, pharmacogenomics, precision medicine, diagnostic testing, genetics testing, gene-drug test
RPRD Diagnostics was founded in 2016.
RPRD Diagnostics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
RPRD Diagnostics has approximately 9 employees.
Top alternatives and competitors to RPRD Diagnostics include RESOLVE MOLECULAR DIAGNOSTICS LLC, Selah Genomics Inc, Genelex, Vibrant Wellness, Xagenic. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RPRD Diagnostics and RESOLVE MOLECULAR DIAGNOSTICS LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors RPRD Diagnostics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy